This is exemplified by the identification of over 300 mutations of BMPR2, which account for approximately 80% of patients with heritable PAH and 25% of patients with idiopathic PAH (Soubrier et al., 2013; West et al., 2014). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.